A new recombinant factor VIII: from genetics to clinical use
Elena Santagostino Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Fondazione IRCCS Ca’ Granda, Ospedale Maggiore Policlinico, Milan, Italy Abstract: Advances in recombinant technology and knowledge about coagulation factor VIII (FVIII) are building a platform for new therapeutic o...
Saved in:
Main Author: | Santagostino E (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2014-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A new recombinant factor VIII: from genetics to clinical use
by: Kannicht C, et al.
Published: (2015) -
Recombinant factor VIII in the management of hemophilia A: current use and future promise
by: Jerry S Powell
Published: (2009) -
GlycoPEGylated recombinant factor IX for hemophilia B in context
by: Santagostino E, et al.
Published: (2018) -
Clinical utility of exemestane in the treatment of breast cancer
by: Zucchini G, et al.
Published: (2015) -
Risk factors for osteoporosis in Japan: is it associated with Helicobacter pylori?
by: Asaoka D, et al.
Published: (2015)